Singapore markets open in 8 hours 12 minutes

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
2.790+0.030 (+1.09%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 12.33B
Enterprise value 15.90B
Trailing P/E 16.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.69
Price/book (mrq)0.31
Enterprise value/revenue 2.92
Enterprise value/EBITDA -47.97

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 3-50.54%
S&P500 52-week change 321.83%
52-week high 35.600
52-week low 32.390
50-day moving average 32.762
200-day moving average 33.586

Share statistics

Avg vol (3-month) 3579.44k
Avg vol (10-day) 3569.67k
Shares outstanding 5220.09M
Implied shares outstanding 64.47B
Float 8479.47M
% held by insiders 15.74%
% held by institutions 11.53%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.11
Forward annual dividend yield 44.06%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 468.21%
Dividend date 3N/A
Ex-dividend date 424 May 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -14.38%
Operating margin (ttm)-50.88%

Management effectiveness

Return on assets (ttm)-0.74%
Return on equity (ttm)-6.58%

Income statement

Revenue (ttm)5.45B
Revenue per share (ttm)3.71
Quarterly revenue growth (yoy)-21.60%
Gross profit (ttm)N/A
Net income avi to common (ttm)-783.26M
Diluted EPS (ttm)-0.580
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.27B
Total cash per share (mrq)1.54
Total debt (mrq)5.56B
Total debt/equity (mrq)46.40%
Current ratio (mrq)2.13
Book value per share (mrq)8.12

Cash flow statement

Operating cash flow (ttm)398.22M
Levered free cash flow (ttm)57.09M